Roundhill GLP-1 & Weight Loss ETF Rating $23.56 -0.13 (-0.55%) As of 03/28/2025 03:38 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.83Holdings in OZEM have an aggregate rating of Moderate Buy based on 223 analyst ratings issued in the past year covering 17 companies (64.8% of the portfolio).OZEM Aggregate Price Target$23.56High Prediction$23.56Average Prediction$23.56Low Prediction$23.56Holdings in OZEM have an aggregate price target of $23.56 and a range of $23.56 to $23.56 covering 17 companies (64.8% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.11%LLYEli Lilly and Company$820.30-0.2%4.8027 of 5 stars2.85$1,009.72 23.1%20Positive News13.25%NVONovo Nordisk A/S$69.36-1.1%4.752 of 5 stars2.80$145.25 109.4%105.12%AZNAstraZeneca$73.79+1.3%2.9617 of 5 stars3.10$89.75 21.6%10Positive News4.63%AMGNAmgen$306.95+0.4%4.4362 of 5 stars2.48$314.04 2.3%23Analyst UpgradePositive News3.64%PFEPfizer$25.20+0.8%4.9866 of 5 stars2.63$31.92 26.7%16Positive News2.62%GILDGilead Sciences$111.79+0.6%4.5863 of 5 stars2.72$105.12 -6.0%29Analyst ForecastPositive News2.56%VKTXViking Therapeutics$25.65-1.8%4.2326 of 5 stars3.00$95.18 271.1%12Analyst Forecast2.54%REGNRegeneron Pharmaceuticals$637.36+0.2%4.8218 of 5 stars2.76$973.13 52.7%25Short Interest ↑Positive News2.23%ALTAltimmune$5.32-4.5%2.6854 of 5 stars2.89$20.83 291.6%9Positive News2.18%GPCRStructure Therapeutics$19.77-0.9%1.9341 of 5 stars3.00$81.29 311.2%81.70%SRRKScholar Rock$32.84-1.6%4.0011 of 5 stars3.00$42.67 29.9%6Analyst ForecastInsider Trade1.60%RYTMRhythm Pharmaceuticals$54.80+2.4%4.413 of 5 stars2.92$69.46 26.8%13Analyst Revision1.58%OPKOPKO Health$1.70-2.3%4.3961 of 5 stars3.00$2.75 61.8%3Insider TradeShort Interest ↑1.32%TERNTerns Pharmaceuticals$2.92-6.4%4.2854 of 5 stars2.60$18.38 529.3%51.29%CORTCorcept Therapeutics$54.63-3.6%4.3471 of 5 stars3.00$99.75 82.6%5Insider Trade1.20%BHVNBiohaven$27.59-2.8%3.8659 of 5 stars3.07$62.77 127.5%150.18%KROSKeros Therapeutics$10.79-1.8%3.6314 of 5 stars2.57$42.33 292.3%14Positive News This page (NASDAQ:OZEM) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
